Browsing byAuthorVajdic, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2022-07Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M
2023-08-22Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M
2020-12-01Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, AustraliaMackenzie, P; Vajdic, C; Delaney, G; Gabriel, G; Agar, M; Comans, T; Barton, M
2023-05OC-0755 Radiotherapy Utilisation and Geriatric Oncology: Lung, Rectal, Prostate and Cervical CancerMackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M
2022-05-01OC-0921 Age- and Comorbidity- Adjusted Optimal Radiotherapy Utilisation Rate for Women with Breast CancerMackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M
2022-10-19Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Morris, L; Agar, M; Gabriel, G; Barton, M
2022-10-01SIOG2022-0007 Development of an Age- and Comorbidity- Adjusted Optimal Radiotherapy Utilisation Rate for Patients with Lung CancerMackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M
2022The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers.Pratt, N; Camacho, X; Vajdic, C; Degenhardt, L; Laba, T-L; Hillen, J; Etherton-Beer, C; Preen, D; Jorm, L; Donnolley, N; Havard, A; Pearson, S-A